Saturday, Jan 18 2025 | Time 05:30 Hrs(IST)
image
Press Releases » PNN


Introducing MIGSPRAY: A Breakthrough Migraine Prevention Treatment

New Delhi (India), February 22:  After five years of diligent research and development, we are excited to introduce  MIGSPRAY,  a ground-breaking preventive treatment for migraines and headache.  MIGSPRAY  is the first natural polymer-based treatment dedicated to the prevention of migraine attacks.  MIGSPRAY  represents a significant leap forward in migraine management, offering a natural solution that can help individuals regain control over their lives.

Migraines affect millions of people worldwide, causing debilitating pain and disrupting daily activities.  MIGSPRAY  is a game-changer in the field of migraine and headache prevention, harnessing the power of natural polymers to address the root causes of migraines.  

What sets  MIGSPRAY  apart is its unique ability to block specific proteins, including CGRP, TNF-alpha, interleukins 6, and 12, known to trigger migraines. The  MIGSPRAY  also detaches and drains these proteins by cleaning the nasal surface by regenerating the nasal mucosa that  provides  relief and enable individuals to breathe easier.

The key Benefits of  MIGSPRAY  include preventing migraine triggers at the source, utilising natural polymers for safe and effective results, non-invasive and easy to use.

"MIGSPRAY  is a testament to our commitment to improving the quality of life for migraine sufferers. We understand the profound impact migraines can have on daily life, and our mission is to provide a groundbreaking solution that offers real relief", said Mr. Pawan Malik, CBO, Curiza Lifesciences.

For more information, please visit:

https://www.instagram.com/migspray/

https://www.facebook.com/migspray

https://www.linkedin.com/company/migspray-nasal-spray

The information provided in this article is for general informational purposes only. We do not endorse or encourage the consumption or subscription of any products or ideas mentioned. It is strongly advised to consult with a physician before considering any ideas or products discussed in this article.

Disclaimer: This is syndicated feed from PR agency and any legal liability for the content is theirs only.

More News

Chandrakant Singh's Being Alive Streams on JioCinema After Cannes Triumph

17 Jan 2025 | 4:24 PM

Chandrakant Singh's Being Alive Streams on JioCinema After Cannes Triumph

see more..

Revolutionizing Water Efficiency: Gurmit Singh Arora on Plumbing Solutions for a Sustainable Future

17 Jan 2025 | 4:50 PM

Revolutionizing Water Efficiency: Gurmit Singh Arora on Plumbing Solutions for a Sustainable Future

see more..

NCPA Mumbai and National Theatre UK Present Connections India's Third Edition for Youth Theatre

17 Jan 2025 | 4:50 PM

NCPA Mumbai and National Theatre UK Present Connections India's Third Edition for Youth Theatre

see more..

Parul University Proudly Hosts the 3rd Edition of IIMUN Vadodara Conclave

17 Jan 2025 | 5:46 PM

Parul University Proudly Hosts the 3rd Edition of IIMUN Vadodara Conclave

see more..

eYantra Ventures raises Rs 15 Crore through preferential issue; eyes global  expansion

17 Jan 2025 | 6:39 PM

eYantra Ventures raises Rs. 15 Crore through preferential issue; eyes global  expansion

see more..
image